BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23803123)

  • 1. Is Helicobacter pylori a poor prognostic factor for HER-2 SISH positive gastric cancer?
    Selcukbiricik F; Tural D; Erdamar S; Buyukunal E; Demirelli F; Serdengecti S
    Asian Pac J Cancer Prev; 2013; 14(5):3319-22. PubMed ID: 23803123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
    Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
    Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epidermal growth factor receptor 2 (HER-2) status evaluation in advanced gastric cancer using immunohistochemistry versus silver in situ hybridization.
    Kepil N; Batur S; Sonmez Wetherilt C; Erdamar Cetin S
    Bosn J Basic Med Sci; 2017 May; 17(2):109-113. PubMed ID: 27579854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study.
    Prins MJ; Ruurda JP; van Diest PJ; van Hillegersberg R; Ten Kate FJ
    Ann Oncol; 2013 May; 24(5):1290-7. PubMed ID: 23334118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.
    Kim YI; Cho SJ; Lee JY; Kim CG; Kook MC; Ryu KW; Kim YW; Choi IJ
    Cancer Res Treat; 2016 Jul; 48(3):1020-9. PubMed ID: 26582396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Helicobacter Pylori associated with Her2/neu Overexpression in Gastric Cancer Patients who Underwent Curative Resection?
    Yoo MW; Han HS; Kim SY; Cho YH; Lee HG; Kim JH; Bang HY; Lee KY; Yoon SY
    Hepatogastroenterology; 2014 May; 61(131):858-62. PubMed ID: 26176087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.
    Oh HS; Eom DW; Kang GH; Ahn YC; Lee SJ; Kim JH; Jang HJ; Kim EJ; Oh KH; Ahn HJ
    Gastric Cancer; 2014; 17(3):402-11. PubMed ID: 23955257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Helicobacter pylori Infection is Associated with Increased Survival After Resection of Gastric Adenocarcinoma.
    Postlewait LM; Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Swords D; Jin LX; Cho CS; Winslow ER; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2016 Apr; 23(4):1225-33. PubMed ID: 26553442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any relationship between Helicobacter pylori infection and human epidermal growth factor receptor 2 expression in gastric cancer?
    Algin E; Baykara M; Yilmaz G; Cetin B; Ekinci O; Uner A; Ozet A
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S128-S132. PubMed ID: 33380666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
    Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study.
    Meimarakis G; Winter H; Assmann I; Kopp R; Lehn N; Kist M; Stolte M; Jauch KW; Hatz RA
    Lancet Oncol; 2006 Mar; 7(3):211-22. PubMed ID: 16510330
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Liu LP; Sheng XP; Shuai TK; Zhao YX; Li B; Li YM
    World J Gastroenterol; 2018 Oct; 24(40):4565-4577. PubMed ID: 30386106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.
    Cho J; Jeong J; Sung J; Sung CO; Kim KM; Park CK; Choi MG; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S477-84. PubMed ID: 23274580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH).
    Boers JE; Meeuwissen H; Methorst N
    Histopathology; 2011 Feb; 58(3):383-94. PubMed ID: 21323962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
    An JY; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Int J Cancer; 2010 Jun; 126(12):2904-13. PubMed ID: 19739122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori.
    Lee WJ; Lin JT; Shun CT; Lee WC; Yu SC; Lee PH; Chang KJ; Wei TC; Chen KM
    Br J Surg; 1995 Jun; 82(6):802-5. PubMed ID: 7627516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric cancer patients with Helicobacter pylori infection have a poor prognosis.
    Li G; Wang Z; Wang Z; Xu J; Cui J; Cai S; Zhan W; He Y
    J Surg Oncol; 2013 Dec; 108(7):421-6. PubMed ID: 24037736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
    Gumusay O; Benekli M; Ekinci O; Baykara M; Ozet A; Coskun U; Demirci U; Uner A; Dursun A; Atak EY; Buyukberber S
    Jpn J Clin Oncol; 2015 May; 45(5):416-21. PubMed ID: 25732909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.